88686161 - IMPACT

Information

  • Trademark
  • 88686161
  • Serial Number
    88686161
  • Registration Number
    6183342
  • Filing Date
    November 09, 2019
    5 years ago
  • Registration Date
    October 27, 2020
    4 years ago
  • Transaction Date
    December 12, 2023
    a year ago
  • Status Date
    November 08, 2023
    a year ago
  • Published for Opposition Date
    August 11, 2020
    4 years ago
  • Location Date
    November 08, 2023
    a year ago
  • First Use Anywhere Date
    May 01, 2017
    7 years ago
  • First Use In Commerce Date
    May 01, 2017
    7 years ago
  • Status Code
    711
  • Current Location
    TMO LAW OFFICE 114
    Employee Name
    JAGANNATHAN, SIDDHARTH
  • Attorney Docket Number
    50180.202084
    Attorney Name
    Cara R. Baer
    Law Office Assigned Location Code
    M50
  • Owners
Mark Drawing Code
4000
Mark Identification
IMPACT
Case File Statements
  • GS0421: Scientific analysis services, namely, neoepitope selection; neoepitope research, development and production of pharmaceuticals comprising personalized adoptive cell therapies; scientific analysis of neoepitopes; research, development and production of pharmaceuticals comprising the selection of and genetic encoding of neoepitopes; research, development and production of pharmaceuticals comprising adoptive cell therapies design of personalized adoptive cell therapies; medical analysis services, namely, detection of truncal cancer mutations in patient tumor cells; developing personal scientific treatment strategies for patients with diagnosed cancer; pharmaceutical product development and evaluation services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials involving neoepitopes; research and development of pharmaceuticals for the treatment of cancer and oncological conditions; research and development of vaccines and medicines; technical research in the field of pharmaceutical studies; development of platform technology, namely, cancer immunotherapy platforms for manufacturing therapeutics; scientific collection of specific molecular and genomic data for analytical and clinical purposes, for the treatment of cancer and other diseases and disorders and for individuals' responses to drug treatments; Conducting early evaluations in the field of new pharmaceuticals; Providing scientific research advice regarding selection of a neoepitope for the design of a cell therapy and/or immunotherapy product
Case File Event Statements
  • 11/9/2023 - a year ago
    20 - NOTICE OF CANCELLATION SEC. 7 SURRENDER EMAILED Type: NCS7
  • 11/8/2023 - a year ago
    19 - CANCELLED SECTION 7-TOTAL Type: C7..
  • 6/16/2023 - a year ago
    18 - REQUEST FOR SECT 7 TOTAL SURRENDER FILED Type: C7RF
  • 11/7/2023 - a year ago
    17 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 11/7/2023 - a year ago
    16 - CASE ASSIGNED TO POST REGISTRATION PARALEGAL Type: APRE
  • 6/16/2023 - a year ago
    15 - TEAS SECTION 7 SURRENDER RECEIVED Type: ES7S
  • 10/27/2020 - 4 years ago
    14 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 8/11/2020 - 4 years ago
    13 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 8/11/2020 - 4 years ago
    12 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 7/22/2020 - 4 years ago
    11 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 7/9/2020 - 4 years ago
    10 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/8/2020 - 4 years ago
    9 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/7/2020 - 4 years ago
    8 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/7/2020 - 4 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 2/20/2020 - 5 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 2/20/2020 - 5 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 2/20/2020 - 5 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 2/13/2020 - 5 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 11/16/2019 - 5 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 11/13/2019 - 5 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP